全身性エリテマトーデス（SLE）治療薬の世界市場：インサイト・予測

• 英文タイトル：Global Systematic Lupus Erythematosus Drug Market Insights, Forecast to 2025

• レポートコード：QYR9ST03045
• 出版社/出版日：QYResearch / 2019年9月2日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、111ページ
• 納品方法：Eメール（受注後2-3営業日）
• 産業分類：化学・材料

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

※本調査レポートでは、世界の全身性エリテマトーデス（SLE）治療薬市場について調査・分析し、以下の構成でお届け致します。全身性エリテマトーデス（SLE）治療薬の種類別には、静脈内、皮下、経口、局所に、用途別には、病院、クリニックに、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。

・調査販売
・エグゼクティブ・サマリー
・企業別全身性エリテマトーデス（SLE）治療薬売上データ
・地域別全身性エリテマトーデス（SLE）治療薬市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他
・種類別全身性エリテマトーデス（SLE）治療薬市場規模：静脈内、皮下、経口、局所
・用途別全身性エリテマトーデス（SLE）治療薬市場規模：病院、クリニック
・主要メーカーの企業情報：Lupus Research、Pfizer、Merck、Eli Lilly、GlaxoSmithKline、Roche、Sanofi、Lycera、Bristol-Myers Squibb、Immupharma
・全身性エリテマトーデス（SLE）治療薬の市場規模予測
・バリューチェーン及び販売チャネル分析
・市場機会・課題・リスク・影響因子分析
...

Systemic lupus erythematosus (SLE) is the chronic, autoimmune disorder which involves multiple organ-systems such as heart, kidney, skin, joints, blood, lungs and, in most severe cases, brain. In this disease, the human immune system becomes hyperactive and attacks the normal, healthy tissues of the body.Global Systematic Lupus Erythematosus Drug market size will increase to xx Million US$ by 2025, from xx Million US$ in 2018, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Systematic Lupus Erythematosus Drug.

This report researches the worldwide Systematic Lupus Erythematosus Drug market size (value, capacity, production and consumption) in key regions like United States, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global Systematic Lupus Erythematosus Drug breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter’s Five Forces Analysis.

The following manufacturers are covered in this report:
Lupus Research
Pfizer
Merck
Eli Lilly
GlaxoSmithKline
Roche
Sanofi
Lycera
Bristol-Myers Squibb
Immupharma

Systematic Lupus Erythematosus Drug Breakdown Data by Type
Intravenous
Sub-cutaneous
Oral
Topical
Systematic Lupus Erythematosus Drug Breakdown Data by Application
Hosptial
Clinic

Systematic Lupus Erythematosus Drug Production Breakdown Data by Region
United States
Europe
China
Japan
Other Regions

Systematic Lupus Erythematosus Drug Consumption Breakdown Data by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Rest of Europe
Central & South America
Brazil
Rest of South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Rest of Middle East & Africa

The study objectives are:
To analyze and research the global Systematic Lupus Erythematosus Drug capacity, production, value, consumption, status and forecast;
To focus on the key Systematic Lupus Erythematosus Drug manufacturers and study the capacity, production, value, market share and development plans in next few years.
To focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Systematic Lupus Erythematosus Drug :
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

Global Systematic Lupus Erythematosus Drug Market Research Report 2019-2025, by Manufacturers, Regions, Types and Applications
1 Study Coverage
1.1 Systematic Lupus Erythematosus Drug Product
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Systematic Lupus Erythematosus Drug Market Size Growth Rate by Type
1.4.2 Intravenous
1.4.3 Sub-cutaneous
1.4.4 Oral
1.4.5 Topical
1.5 Market by Application
1.5.1 Global Systematic Lupus Erythematosus Drug Market Size Growth Rate by Application
1.5.2 Hosptial
1.5.3 Clinic
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Systematic Lupus Erythematosus Drug Production
2.1.1 Global Systematic Lupus Erythematosus Drug Revenue 2014-2025
2.1.2 Global Systematic Lupus Erythematosus Drug Production 2014-2025
2.1.3 Global Systematic Lupus Erythematosus Drug Capacity 2014-2025
2.1.4 Global Systematic Lupus Erythematosus Drug Marketing Pricing and Trends
2.2 Systematic Lupus Erythematosus Drug Growth Rate (CAGR) 2019-2025
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Key Systematic Lupus Erythematosus Drug Manufacturers
2.4 Market Drivers, Trends and Issues
2.5 Macroscopic Indicator
2.5.1 GDP for Major Regions
2.5.2 Price of Raw Materials in Dollars: Evolution

3 Market Size by Manufacturers
3.1 Systematic Lupus Erythematosus Drug Production by Manufacturers
3.1.1 Systematic Lupus Erythematosus Drug Production by Manufacturers
3.1.2 Systematic Lupus Erythematosus Drug Production Market Share by Manufacturers
3.2 Systematic Lupus Erythematosus Drug Revenue by Manufacturers
3.2.1 Systematic Lupus Erythematosus Drug Revenue by Manufacturers (2014-2019)
3.2.2 Systematic Lupus Erythematosus Drug Revenue Share by Manufacturers (2014-2019)
3.3 Systematic Lupus Erythematosus Drug Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans

4 Systematic Lupus Erythematosus Drug Production by Regions
4.1 Global Systematic Lupus Erythematosus Drug Production by Regions
4.1.1 Global Systematic Lupus Erythematosus Drug Production Market Share by Regions
4.1.2 Global Systematic Lupus Erythematosus Drug Revenue Market Share by Regions
4.2 United States
4.2.1 United States Systematic Lupus Erythematosus Drug Production
4.2.2 United States Systematic Lupus Erythematosus Drug Revenue
4.2.3 Key Players in United States
4.2.4 United States Systematic Lupus Erythematosus Drug Import & Export
4.3 Europe
4.3.1 Europe Systematic Lupus Erythematosus Drug Production
4.3.2 Europe Systematic Lupus Erythematosus Drug Revenue
4.3.3 Key Players in Europe
4.3.4 Europe Systematic Lupus Erythematosus Drug Import & Export
4.4 China
4.4.1 China Systematic Lupus Erythematosus Drug Production
4.4.2 China Systematic Lupus Erythematosus Drug Revenue
4.4.3 Key Players in China
4.4.4 China Systematic Lupus Erythematosus Drug Import & Export
4.5 Japan
4.5.1 Japan Systematic Lupus Erythematosus Drug Production
4.5.2 Japan Systematic Lupus Erythematosus Drug Revenue
4.5.3 Key Players in Japan
4.5.4 Japan Systematic Lupus Erythematosus Drug Import & Export
4.6 Other Regions
4.6.1 South Korea
4.6.2 India
4.6.3 Southeast Asia

5 Systematic Lupus Erythematosus Drug Consumption by Regions
5.1 Global Systematic Lupus Erythematosus Drug Consumption by Regions
5.1.1 Global Systematic Lupus Erythematosus Drug Consumption by Regions
5.1.2 Global Systematic Lupus Erythematosus Drug Consumption Market Share by Regions
5.2 North America
5.2.1 North America Systematic Lupus Erythematosus Drug Consumption by Application
5.2.2 North America Systematic Lupus Erythematosus Drug Consumption by Countries
5.2.3 United States
5.2.4 Canada
5.2.5 Mexico
5.3 Europe
5.3.1 Europe Systematic Lupus Erythematosus Drug Consumption by Application
5.3.2 Europe Systematic Lupus Erythematosus Drug Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 UK
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Systematic Lupus Erythematosus Drug Consumption by Application
5.4.2 Asia Pacific Systematic Lupus Erythematosus Drug Consumption by Countries
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Indonesia
5.4.9 Thailand
5.4.10 Malaysia
5.4.11 Philippines
5.4.12 Vietnam
5.5 Central & South America
5.5.1 Central & South America Systematic Lupus Erythematosus Drug Consumption by Application
5.5.2 Central & South America Systematic Lupus Erythematosus Drug Consumption by Countries
5.5.3 Brazil
5.6 Middle East and Africa
5.6.1 Middle East and Africa Systematic Lupus Erythematosus Drug Consumption by Application
5.6.2 Middle East and Africa Systematic Lupus Erythematosus Drug Consumption by Countries
5.6.3 Turkey
5.6.4 GCC Countries
5.6.5 Egypt
5.6.6 South Africa

6 Market Size by Type
6.1 Global Systematic Lupus Erythematosus Drug Breakdown Dada by Type
6.2 Global Systematic Lupus Erythematosus Drug Revenue by Type
6.3 Systematic Lupus Erythematosus Drug Price by Type

7 Market Size by Application
7.1 Overview
7.2 Global Systematic Lupus Erythematosus Drug Breakdown Dada by Application
7.2.1 Global Systematic Lupus Erythematosus Drug Consumption by Application
7.2.2 Global Systematic Lupus Erythematosus Drug Consumption Market Share by Application (2014-2019)

8 Manufacturers Profiles
8.1 Lupus Research
8.1.1 Lupus Research Company Details
8.1.2 Company Description
8.1.3 Capacity, Production and Value of Systematic Lupus Erythematosus Drug
8.1.4 Systematic Lupus Erythematosus Drug Product Description
8.1.5 SWOT Analysis
8.2 Pfizer
8.2.1 Pfizer Company Details
8.2.2 Company Description
8.2.3 Capacity, Production and Value of Systematic Lupus Erythematosus Drug
8.2.4 Systematic Lupus Erythematosus Drug Product Description
8.2.5 SWOT Analysis
8.3 Merck
8.3.1 Merck Company Details
8.3.2 Company Description
8.3.3 Capacity, Production and Value of Systematic Lupus Erythematosus Drug
8.3.4 Systematic Lupus Erythematosus Drug Product Description
8.3.5 SWOT Analysis
8.4 Eli Lilly
8.4.1 Eli Lilly Company Details
8.4.2 Company Description
8.4.3 Capacity, Production and Value of Systematic Lupus Erythematosus Drug
8.4.4 Systematic Lupus Erythematosus Drug Product Description
8.4.5 SWOT Analysis
8.5 GlaxoSmithKline
8.5.1 GlaxoSmithKline Company Details
8.5.2 Company Description
8.5.3 Capacity, Production and Value of Systematic Lupus Erythematosus Drug
8.5.4 Systematic Lupus Erythematosus Drug Product Description
8.5.5 SWOT Analysis
8.6 Roche
8.6.1 Roche Company Details
8.6.2 Company Description
8.6.3 Capacity, Production and Value of Systematic Lupus Erythematosus Drug
8.6.4 Systematic Lupus Erythematosus Drug Product Description
8.6.5 SWOT Analysis
8.7 Sanofi
8.7.1 Sanofi Company Details
8.7.2 Company Description
8.7.3 Capacity, Production and Value of Systematic Lupus Erythematosus Drug
8.7.4 Systematic Lupus Erythematosus Drug Product Description
8.7.5 SWOT Analysis
8.8 Lycera
8.8.1 Lycera Company Details
8.8.2 Company Description
8.8.3 Capacity, Production and Value of Systematic Lupus Erythematosus Drug
8.8.4 Systematic Lupus Erythematosus Drug Product Description
8.8.5 SWOT Analysis
8.9 Bristol-Myers Squibb
8.9.1 Bristol-Myers Squibb Company Details
8.9.2 Company Description
8.9.3 Capacity, Production and Value of Systematic Lupus Erythematosus Drug
8.9.4 Systematic Lupus Erythematosus Drug Product Description
8.9.5 SWOT Analysis
8.10 Immupharma
8.10.1 Immupharma Company Details
8.10.2 Company Description
8.10.3 Capacity, Production and Value of Systematic Lupus Erythematosus Drug
8.10.4 Systematic Lupus Erythematosus Drug Product Description
8.10.5 SWOT Analysis

9 Production Forecasts
9.1 Systematic Lupus Erythematosus Drug Production and Revenue Forecast
9.1.1 Global Systematic Lupus Erythematosus Drug Production Forecast 2019-2025
9.1.2 Global Systematic Lupus Erythematosus Drug Revenue Forecast 2019-2025
9.2 Systematic Lupus Erythematosus Drug Production and Revenue Forecast by Regions
9.2.1 Global Systematic Lupus Erythematosus Drug Revenue Forecast by Regions
9.2.2 Global Systematic Lupus Erythematosus Drug Production Forecast by Regions
9.3 Systematic Lupus Erythematosus Drug Key Producers Forecast
9.3.1 United States
9.3.2 Europe
9.3.3 China
9.3.4 Japan
9.4 Forecast by Type
9.4.1 Global Systematic Lupus Erythematosus Drug Production Forecast by Type
9.4.2 Global Systematic Lupus Erythematosus Drug Revenue Forecast by Type

10 Consumption Forecast
10.1 Consumption Forecast by Application
10.2 Systematic Lupus Erythematosus Drug Consumption Forecast by Regions
10.3 North America Market Consumption Forecast
10.3.1 North America Systematic Lupus Erythematosus Drug Consumption Forecast by Countries 2019-2025
10.3.2 United States
10.3.3 Canada
10.3.4 Mexico
10.4 Europe Market Consumption Forecast
10.4.1 Europe Systematic Lupus Erythematosus Drug Consumption Forecast by Countries 2019-2025
10.4.2 Germany
10.4.3 France
10.4.4 UK
10.4.5 Italy
10.4.6 Russia
10.5 Asia Pacific Market Consumption Forecast
10.5.1 Asia Pacific Systematic Lupus Erythematosus Drug Consumption Forecast by Countries 2019-2025
10.5.2 China
10.5.3 Japan
10.5.4 Korea
10.5.5 India
10.5.6 Australia
10.5.7 Indonesia
10.5.8 Thailand
10.5.9 Malaysia
10.5.10 Philippines
10.5.11 Vietnam
10.6 Central & South America Market Consumption Forecast
10.6.1 Central & South America Systematic Lupus Erythematosus Drug Consumption Forecast by Country 2019-2025
10.6.2 Brazil
10.7 Middle East and Africa Market Consumption Forecast
10.7.1 Middle East and Africa Systematic Lupus Erythematosus Drug Consumption Forecast by Countries 2019-2025
10.7.2 Middle East and Africa
10.7.3 Turkey
10.7.4 GCC Countries
10.7.5 Egypt
10.7.6 South Africa

11 Upstream, Industry Chain and Downstream Customers Analysis
11.1 Analysis of Systematic Lupus Erythematosus Drug Upstream Market
11.1.1 Systematic Lupus Erythematosus Drug Key Raw Material
11.1.2 Typical Suppliers of Key Systematic Lupus Erythematosus Drug Raw Material
11.1.3 Systematic Lupus Erythematosus Drug Raw Material Market Concentration Rate
11.2 Systematic Lupus Erythematosus Drug Industry Chain Analysis
11.3 Marketing & Distribution
11.4 Systematic Lupus Erythematosus Drug Distributors
11.5 Systematic Lupus Erythematosus Drug Customers

12 Opportunities & Challenges, Threat and Affecting Factors
12.1 Market Opportunities
12.2 Market Challenges
12.3 Porter’s Five Forces Analysis

13 Key Findings

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Tables and Figures

Figure Systematic Lupus Erythematosus Drug Product Picture
Table Systematic Lupus Erythematosus Drug Key Market Segments in This Study
Table Key Manufacturers Systematic Lupus Erythematosus Drug Covered in This Study
Table Global Systematic Lupus Erythematosus Drug Market Size Growth Rate by Type 2019-2025 (K Units) & (Million US$)
Figure Global Systematic Lupus Erythematosus Drug Production Market Share 2014-2025
Figure Intravenous Product Picture
Table Major Manufacturers of Intravenous
Figure Sub-cutaneous Product Picture
Table Major Manufacturers of Sub-cutaneous
Figure Oral Product Picture
Table Major Manufacturers of Oral
Figure Topical Product Picture
Table Major Manufacturers of Topical
Table Global Systematic Lupus Erythematosus Drug Market Size Growth Rate by Application 2019-2025 (K Units)
Figure Hosptial
Figure Clinic
Figure Systematic Lupus Erythematosus Drug Report Years Considered
Figure Global Systematic Lupus Erythematosus Drug Revenue 2014-2025 (Million US$)
Figure Global Systematic Lupus Erythematosus Drug Production 2014-2025 (K Units)
Figure Global Systematic Lupus Erythematosus Drug Capacity 2014-2025 (K Units)
Table Key Manufacturers Systematic Lupus Erythematosus Drug Capacity (K Units)
Figure Global Systematic Lupus Erythematosus Drug Price 2014-2025 (USD/Unit)
Table Global Systematic Lupus Erythematosus Drug Market Size Growth Rate by Regions 2019-2025(K Units) & (Million US$)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Systematic Lupus Erythematosus Drug Manufacturing Base Distribution and Headquarters
Table Manufacturers Systematic Lupus Erythematosus Drug Product Offered
Table Date of Manufacturers Enter into Systematic Lupus Erythematosus Drug Market
Table Global Systematic Lupus Erythematosus Drug Production by Manufacturers (2014-2019) (K Units)
Table Global Systematic Lupus Erythematosus Drug Production Share by Manufacturers (2014-2019)
Figure Global Systematic Lupus Erythematosus Drug Production Share by Manufacturers in 2018
Table Systematic Lupus Erythematosus Drug Revenue by Manufacturers (2014-2019) (Million US$)
Table Systematic Lupus Erythematosus Drug Revenue Share by Manufacturers (2014-2019)
Figure Systematic Lupus Erythematosus Drug Value Share by Manufacturers in 2018
Table Systematic Lupus Erythematosus Drug Price by Manufacturers 2014-2019 (USD/Unit)
Table Mergers & Acquisitions, Expansion Plans
Table Global Systematic Lupus Erythematosus Drug Production by Regions 2014-2019 (K Units)
Table Global Systematic Lupus Erythematosus Drug Production Market Share by Regions 2014-2019
Figure Global Systematic Lupus Erythematosus Drug Production Market Share by Regions 2014-2019
Figure Global Systematic Lupus Erythematosus Drug Production Market Share by Regions in 2018
Table Global Systematic Lupus Erythematosus Drug Revenue by Regions 2014-2019 (Million US$)
Table Global Systematic Lupus Erythematosus Drug Revenue Market Share by Regions 2014-2019
Figure Global Systematic Lupus Erythematosus Drug Revenue Market Share by Regions 2014-2019
Figure Global Systematic Lupus Erythematosus Drug Revenue Market Share by Regions in 2018
Figure United States Systematic Lupus Erythematosus Drug Production and Growth Rate 2014-2019 (K Units)
Figure United States Systematic Lupus Erythematosus Drug Revenue and Growth Rate 2014-2019 (Million US$)
Table United States Systematic Lupus Erythematosus Drug Import & Export
Figure Europe Systematic Lupus Erythematosus Drug Production and Growth Rate 2014-2019 (K Units)
Figure Europe Systematic Lupus Erythematosus Drug Revenue and Growth Rate 2014-2019 (Million US$)
Table Europe Systematic Lupus Erythematosus Drug Import & Export
Figure China Systematic Lupus Erythematosus Drug Production and Growth Rate 2014-2019 (K Units)
Figure China Systematic Lupus Erythematosus Drug Revenue and Growth Rate 2014-2019 (Million US$)
Table China Systematic Lupus Erythematosus Drug Import & Export
Figure Japan Systematic Lupus Erythematosus Drug Production and Growth Rate 2014-2019 (K Units)
Figure Japan Systematic Lupus Erythematosus Drug Revenue and Growth Rate 2014-2019 (Million US$)
Table Japan Systematic Lupus Erythematosus Drug Import & Export
Table Global Systematic Lupus Erythematosus Drug Consumption by Regions 2014-2019 (K Units)
Table Global Systematic Lupus Erythematosus Drug Consumption Market Share by Regions 2014-2019
Figure Global Systematic Lupus Erythematosus Drug Consumption Market Share by Regions 2014-2019
Figure Global Systematic Lupus Erythematosus Drug Consumption Market Share by Regions in 2018
Figure North America Systematic Lupus Erythematosus Drug Consumption and Growth Rate (2014-2019) (K Units)
Table North America Systematic Lupus Erythematosus Drug Consumption by Application (2014-2019) (K Units)
Figure 2018 North America Systematic Lupus Erythematosus Drug Consumption Market Share by Application
Table North America Systematic Lupus Erythematosus Drug Consumption by Countries (2014-2019) (K Units)
Figure 2018 North America Systematic Lupus Erythematosus Drug Consumption Market Share by Countries
Figure United States Systematic Lupus Erythematosus Drug Consumption and Growth Rate (2014-2019) (K Units)
Figure Canada Systematic Lupus Erythematosus Drug Consumption (K Units) and Growth Rate (2014-2019)
Figure Mexico Systematic Lupus Erythematosus Drug Consumption (K Units) and Growth Rate (2014-2019)
Figure Europe Systematic Lupus Erythematosus Drug Consumption and Growth Rate (2014-2019) (K Units)
Table Europe Systematic Lupus Erythematosus Drug Consumption by Application (2014-2019) (K Units)
Figure 2018 Europe Systematic Lupus Erythematosus Drug Consumption Market Share by Application
Table Europe Systematic Lupus Erythematosus Drug Consumption by Countries (2014-2019) (K Units)
Figure 2018 Europe Systematic Lupus Erythematosus Drug Consumption Market Share by Countries
Figure Germany Systematic Lupus Erythematosus Drug Consumption and Growth Rate (2014-2019) (K Units)
Figure France Systematic Lupus Erythematosus Drug Consumption and Growth Rate (2014-2019) (K Units)
Figure UK Systematic Lupus Erythematosus Drug Consumption and Growth Rate (2014-2019) (K Units)
Figure Italy Systematic Lupus Erythematosus Drug Consumption and Growth Rate (2014-2019) (K Units)
Figure Russia Systematic Lupus Erythematosus Drug Consumption and Growth Rate (2014-2019) (K Units)
Figure Asia Pacific Systematic Lupus Erythematosus Drug Consumption and Growth Rate (2014-2019) (K Units)
Table Asia Pacific Systematic Lupus Erythematosus Drug Consumption by Application (2014-2019) (K Units)
Table Asia Pacific Systematic Lupus Erythematosus Drug Consumption Market Share by Application (2014-2019) (K Units)
Table Asia Pacific Systematic Lupus Erythematosus Drug Consumption by Countries (2014-2019) (K Units)
Table Asia Pacific Systematic Lupus Erythematosus Drug Consumption Market Share by Countries (2014-2019) (K Units)
Figure China Systematic Lupus Erythematosus Drug Consumption and Growth Rate (2014-2019) (K Units)
Figure Japan Systematic Lupus Erythematosus Drug Consumption and Growth Rate (2014-2019) (K Units)
Figure Korea Systematic Lupus Erythematosus Drug Consumption and Growth Rate (2014-2019) (K Units)
Figure India Systematic Lupus Erythematosus Drug Consumption and Growth Rate (2014-2019) (K Units)
Figure Australia Systematic Lupus Erythematosus Drug Consumption and Growth Rate (2014-2019) (K Units)
Figure Indonesia Systematic Lupus Erythematosus Drug Consumption and Growth Rate (2014-2019) (K Units)
Figure Thailand Systematic Lupus Erythematosus Drug Consumption and Growth Rate (2014-2019) (K Units)
Figure Malaysia Systematic Lupus Erythematosus Drug Consumption and Growth Rate (2014-2019) (K Units)
Figure Philippines Systematic Lupus Erythematosus Drug Consumption and Growth Rate (2014-2019) (K Units)
Figure Vietnam Systematic Lupus Erythematosus Drug Consumption and Growth Rate (2014-2019) (K Units)
Figure Central & South America Systematic Lupus Erythematosus Drug Consumption and Growth Rate (K Units)
Table Central & South America Systematic Lupus Erythematosus Drug Consumption by Application (2014-2019) (K Units)
Figure 2017 Central & South America Systematic Lupus Erythematosus Drug Consumption Market Share by Application
Table Central & South America Systematic Lupus Erythematosus Drug Consumption by Countries (2014-2019) (K Units)
Figure Central & South America Systematic Lupus Erythematosus Drug Consumption Market Share by Countries
Figure Brazil Systematic Lupus Erythematosus Drug Consumption and Growth Rate (2014-2019) (K Units)
Figure Middle East and Africa Systematic Lupus Erythematosus Drug Consumption and Growth Rate (K Units)
Table Middle East and Africa Systematic Lupus Erythematosus Drug Consumption by Application (2014-2019) (K Units)
Figure 2018 Middle East and Africa Systematic Lupus Erythematosus Drug Consumption Market Share by Application
Table Middle East and Africa Systematic Lupus Erythematosus Drug Consumption by Countries (2014-2019) (K Units)
Figure Middle East and Africa Systematic Lupus Erythematosus Drug Consumption Market Share by Countries
Figure Turkey Systematic Lupus Erythematosus Drug Consumption and Growth Rate (2014-2019) (K Units)
Figure GCC Countries Systematic Lupus Erythematosus Drug Consumption and Growth Rate (2014-2019) (K Units)
Figure Egypt Systematic Lupus Erythematosus Drug Consumption and Growth Rate (2014-2019) (K Units)
Figure South Africa Systematic Lupus Erythematosus Drug Consumption and Growth Rate (2014-2019) (K Units)
Table Global Systematic Lupus Erythematosus Drug Production by Type (2014-2019) (K Units)
Table Global Systematic Lupus Erythematosus Drug Production Share by Type (2014-2019)
Figure Global Systematic Lupus Erythematosus Drug Production Market Share by Type (2014-2019)
Figure Global Systematic Lupus Erythematosus Drug Production Market Share by Type in 2018
Table Global Systematic Lupus Erythematosus Drug Revenue by Type (2014-2019) (Million US$)
Table Global Systematic Lupus Erythematosus Drug Revenue Share by Type (2014-2019)
Figure Global Systematic Lupus Erythematosus Drug Revenue Market Share by Type (2014-2019)
Figure Global Systematic Lupus Erythematosus Drug Revenue Market Share by Type in 2018
Table Systematic Lupus Erythematosus Drug Price by Type 2014-2019 (USD/Unit)
Table Global Systematic Lupus Erythematosus Drug Consumption by Application (2014-2025) (K Units)
Table Global Systematic Lupus Erythematosus Drug Consumption by Application (2014-2019) (K Units)
Table Global Systematic Lupus Erythematosus Drug Consumption Share by Application (2014-2019)
Figure Global Systematic Lupus Erythematosus Drug Consumption Market Share by Application (2014-2019)
Figure Global Systematic Lupus Erythematosus Drug Value (Consumption) Market Share by Application (2014-2019)
Table Lupus Research Company Details
Table Lupus Research Systematic Lupus Erythematosus Drug Capacity, Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Lupus Research Systematic Lupus Erythematosus Drug Production Growth Rate (2014-2019)
Figure Lupus Research Systematic Lupus Erythematosus Drug Production Market Share in Global Market
Table Lupus Research Systematic Lupus Erythematosus Drug SWOT Analysis
Table Pfizer Company Details
Table Pfizer Systematic Lupus Erythematosus Drug Capacity, Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Pfizer Systematic Lupus Erythematosus Drug Production Growth Rate (2014-2019)
Figure Pfizer Systematic Lupus Erythematosus Drug Production Market Share in Global Market
Table Pfizer Systematic Lupus Erythematosus Drug SWOT Analysis
Table Merck Company Details
Table Merck Systematic Lupus Erythematosus Drug Capacity, Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Merck Systematic Lupus Erythematosus Drug Production Growth Rate (2014-2019)
Figure Merck Systematic Lupus Erythematosus Drug Production Market Share in Global Market
Table Merck Systematic Lupus Erythematosus Drug SWOT Analysis
Table Eli Lilly Company Details
Table Eli Lilly Systematic Lupus Erythematosus Drug Capacity, Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Eli Lilly Systematic Lupus Erythematosus Drug Production Growth Rate (2014-2019)
Figure Eli Lilly Systematic Lupus Erythematosus Drug Production Market Share in Global Market
Table Eli Lilly Systematic Lupus Erythematosus Drug SWOT Analysis
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Systematic Lupus Erythematosus Drug Capacity, Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Figure GlaxoSmithKline Systematic Lupus Erythematosus Drug Production Growth Rate (2014-2019)
Figure GlaxoSmithKline Systematic Lupus Erythematosus Drug Production Market Share in Global Market
Table GlaxoSmithKline Systematic Lupus Erythematosus Drug SWOT Analysis
Table Roche Company Details
Table Roche Systematic Lupus Erythematosus Drug Capacity, Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Roche Systematic Lupus Erythematosus Drug Production Growth Rate (2014-2019)
Figure Roche Systematic Lupus Erythematosus Drug Production Market Share in Global Market
Table Roche Systematic Lupus Erythematosus Drug SWOT Analysis
Table Sanofi Company Details
Table Sanofi Systematic Lupus Erythematosus Drug Capacity, Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Sanofi Systematic Lupus Erythematosus Drug Production Growth Rate (2014-2019)
Figure Sanofi Systematic Lupus Erythematosus Drug Production Market Share in Global Market
Table Sanofi Systematic Lupus Erythematosus Drug SWOT Analysis
Table Lycera Company Details
Table Lycera Systematic Lupus Erythematosus Drug Capacity, Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Lycera Systematic Lupus Erythematosus Drug Production Growth Rate (2014-2019)
Figure Lycera Systematic Lupus Erythematosus Drug Production Market Share in Global Market
Table Lycera Systematic Lupus Erythematosus Drug SWOT Analysis
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Systematic Lupus Erythematosus Drug Capacity, Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Bristol-Myers Squibb Systematic Lupus Erythematosus Drug Production Growth Rate (2014-2019)
Figure Bristol-Myers Squibb Systematic Lupus Erythematosus Drug Production Market Share in Global Market
Table Bristol-Myers Squibb Systematic Lupus Erythematosus Drug SWOT Analysis
Table Immupharma Company Details
Table Immupharma Systematic Lupus Erythematosus Drug Capacity, Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
Figure Immupharma Systematic Lupus Erythematosus Drug Production Growth Rate (2014-2019)
Figure Immupharma Systematic Lupus Erythematosus Drug Production Market Share in Global Market
Table Immupharma Systematic Lupus Erythematosus Drug SWOT Analysis
Figure Global Systematic Lupus Erythematosus Drug Production Forecast 2019-2025 (K Units)
Figure Global Systematic Lupus Erythematosus Drug Revenue Forecast 2019-2025 (Million US$)
Table Global Systematic Lupus Erythematosus Drug Revenue Forecast 2019-2025 (Million US$)
Table Global Systematic Lupus Erythematosus Drug Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global Systematic Lupus Erythematosus Drug Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global Systematic Lupus Erythematosus Drug Revenue Market Share Forecast by Regions 2019-2025
Table Global Systematic Lupus Erythematosus Drug Production Forecast by Regions 2019-2025 (K Units)
Figure Global Systematic Lupus Erythematosus Drug Production Forecast by Regions 2019-2025 (K Units)
Figure Global Systematic Lupus Erythematosus Drug Production Market Share Forecast by Regions 2019-2025
Figure United States Systematic Lupus Erythematosus Drug Production Forecast 2019-2025 (K Units)
Figure United States Systematic Lupus Erythematosus Drug Revenue Forecast 2019-2025 (Million US$)
Figure Europe Systematic Lupus Erythematosus Drug Production Forecast 2019-2025 (K Units)
Figure Europe Systematic Lupus Erythematosus Drug Revenue Forecast 2019-2025 (Million US$)
Figure China Systematic Lupus Erythematosus Drug Production Forecast 2019-2025 (K Units)
Figure China Systematic Lupus Erythematosus Drug Revenue Forecast 2019-2025 (Million US$)
Figure Japan Systematic Lupus Erythematosus Drug Production Forecast 2019-2025 (K Units)
Figure Japan Systematic Lupus Erythematosus Drug Revenue Forecast 2019-2025 (Million US$)
Table Global Systematic Lupus Erythematosus Drug Production Forecast by Type 2019-2025 (K Units)
Figure Global Systematic Lupus Erythematosus Drug Production Forecast by Type 2019-2025 (K Units)
Figure Global Systematic Lupus Erythematosus Drug Production Market Share Forecast by Type 2019-2025
Table Global Systematic Lupus Erythematosus Drug Revenue Forecast by Type 2019-2025 (Million US$)
Figure Global Systematic Lupus Erythematosus Drug Revenue Forecast by Type 2019-2025 (Million US$)
Figure Global Systematic Lupus Erythematosus Drug Revenue Market Share Forecast by Type 2019-2025
Table Global Systematic Lupus Erythematosus Drug Consumption Forecast by Application 2019-2025 (K Units)
Figure Global Systematic Lupus Erythematosus Drug Consumption Forecast by Application 2019-2025 (K Units)
Figure Global Systematic Lupus Erythematosus Drug Consumption Market Share Forecast by Application 2019-2025
Table Global Systematic Lupus Erythematosus Drug Consumption Forecast by Regions 2019-2025 (K Units)
Figure Global Systematic Lupus Erythematosus Drug Consumption Forecast by Regions 2019-2025 (K Units)
Figure Global Systematic Lupus Erythematosus Drug Consumption Market Share Forecast by Regions 2019-2025
Table North America Systematic Lupus Erythematosus Drug Consumption Forecast by Regions 2019-2025 (K Units)
Figure United States Systematic Lupus Erythematosus Drug Consumption Forecast 2019-2025 (K Units)
Figure Canada Systematic Lupus Erythematosus Drug Consumption Forecast 2019-2025 (K Units)
Figure MexicoSystematic Lupus Erythematosus Drug Consumption Forecast 2019-2025 (K Units)
Table Europe Systematic Lupus Erythematosus Drug Consumption Forecast by Regions 2019-2025 (K Units)
Figure Germany Systematic Lupus Erythematosus Drug Consumption Forecast 2019-2025 (K Units)
Figure France Systematic Lupus Erythematosus Drug Consumption Forecast 2019-2025 (K Units)
Figure UK Systematic Lupus Erythematosus Drug Consumption Forecast 2019-2025 (K Units)
Figure Italy Systematic Lupus Erythematosus Drug Consumption Forecast 2019-2025 (K Units)
Figure Russia Systematic Lupus Erythematosus Drug Consumption Forecast 2019-2025 (K Units)
Table Asia Pacific Systematic Lupus Erythematosus Drug Consumption Forecast by Regions 2019-2025 (K Units)
Figure China Systematic Lupus Erythematosus Drug Consumption Forecast 2019-2025 (K Units)
Figure Japan Systematic Lupus Erythematosus Drug Consumption Forecast 2019-2025 (K Units)
Figure Korea Systematic Lupus Erythematosus Drug Consumption Forecast 2019-2025 (K Units)
Figure India Systematic Lupus Erythematosus Drug Consumption Forecast 2019-2025 (K Units)
Figure Australia Systematic Lupus Erythematosus Drug Consumption Forecast 2019-2025 (K Units)
Figure Indonesia Systematic Lupus Erythematosus Drug Consumption Forecast 2019-2025 (K Units)
Figure Thailand Systematic Lupus Erythematosus Drug Consumption Forecast 2019-2025 (K Units)
Figure Malaysia Systematic Lupus Erythematosus Drug Consumption Forecast 2019-2025 (K Units)
Figure Philippines Systematic Lupus Erythematosus Drug Consumption Forecast 2019-2025 (K Units)
Figure Vietnam Systematic Lupus Erythematosus Drug Consumption Forecast 2019-2025 (K Units)
Table Central & South America Systematic Lupus Erythematosus Drug Consumption Forecast by Regions 2019-2025 (K Units)
Figure Brazil Systematic Lupus Erythematosus Drug Consumption Forecast 2019-2025 (K Units)
Table Middle East and Africa Systematic Lupus Erythematosus Drug Consumption Forecast by Regions 2019-2025 (K Units)
Figure Middle East and Africa Systematic Lupus Erythematosus Drug Consumption Forecast 2019-2025 (K Units)
Figure Turkey Systematic Lupus Erythematosus Drug Consumption Forecast 2019-2025 (K Units)
Figure GCC Countries Systematic Lupus Erythematosus Drug Consumption Forecast 2019-2025 (K Units)
Figure Egypt Systematic Lupus Erythematosus Drug Consumption Forecast 2019-2025 (K Units)
Figure South Africa Systematic Lupus Erythematosus Drug Consumption Forecast 2019-2025 (K Units)
Table Systematic Lupus Erythematosus Drug Key Raw Material
Table Typical Suppliers of Key Systematic Lupus Erythematosus Drug Raw Material
Figure Systematic Lupus Erythematosus Drug Industry Chain
Table Distributors/Traders List
Table Systematic Lupus Erythematosus Drug Customers List
Table Porter’s Five Forces Analysis
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

全身性エリテマトーデスSLE治療薬の世界市場：インサイト・予測

Global Systemic Lupus Erythematous SLE Drug Market Insights, Forecast to 2025
QYR9ST00699 2019年9月2日 112Pages
※本調査レポートでは、世界の全身性エリテマトーデスSLE治療薬市場について調査・分析し、以下の構成でお届け致します。全身性エリテマトーデスSLE治療薬の種類別には、コルチコステロイド、非ステロイド系抗炎症薬（NSAID）、抗炎症薬、疾患修飾性抗リウマチ薬（DMARD）、抗マラリア薬、BLyS特異的阻...

心的外傷後ストレス障害（PTSD）治療薬の世界市場：インサイト・予測

Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market Insights, Forecast to 2025
QYR9ST02997 2019年9月2日 117Pages
※本調査レポートでは、世界の心的外傷後ストレス障害（PTSD）治療薬市場について調査・分析し、以下の構成でお届け致します。心的外傷後ストレス障害（PTSD）治療薬の種類別には、抗うつ薬、抗不安薬に、用途別には、病院、薬局、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国...

急性骨髄性白血病（AML）治療薬の世界市場：市場規模・現状・予測

Global Acute Myeloid Leukemia (AML) Therapeutics Market Size, Status and Forecast 2019-2025
QYR9ST03568 2019年9月2日 96Pages
※当調査レポートでは、急性骨髄性白血病（AML）治療薬の世界市場について調査・分析し、急性骨髄性白血病（AML）治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（化学療法、放射線療法、幹細胞移植...

急性骨髄性白血病（AML）治療薬の世界市場：市場規模・現状・予測

Global Acute Myeloid Leukemia Therapeutics Market Size, Status and Forecast 2019-2025
QYR9ST04687 2019年9月2日 90Pages
※当調査レポートでは、急性骨髄性白血病（AML）治療薬の世界市場について調査・分析し、急性骨髄性白血病（AML）治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（パイプライン薬、化学療法薬、化学...

短腸症候群（SBS）治療薬の世界市場：市場規模・現状・予測

Global Short Bowel Syndrome (SBS) Drugs Market Size, Status and Forecast 2019-2025
QYR9ST04542 2019年9月2日 98Pages
※当調査レポートでは、短腸症候群（SBS）治療薬の世界市場について調査・分析し、短腸症候群（SBS）治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（グルカゴン様ペプチド-2（GLP-2）、成長...

末梢動脈疾患（PAD）治療薬の世界市場：市場規模・現状・予測

Global Peripheral Arterial Disease (PAD) Therapeutics Market Size, Status and Forecast 2019-2025
QYR9ST04523 2019年9月2日 99Pages
※当調査レポートでは、末梢動脈疾患（PAD）治療薬の世界市場について調査・分析し、末梢動脈疾患（PAD）治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（抗血小板薬、二重抗血小板療法薬、その他）...

クラミジア感染診断・治療薬の世界市場：市場規模・現状・予測

Global Chlamydia Infection Diagnostics and Therapeutics Market Size, Status and Forecast 2019-2025
QYR9ST03607 2019年9月2日 92Pages
※当調査レポートでは、クラミジア感染診断・治療薬の世界市場について調査・分析し、クラミジア感染診断・治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（核酸増幅試験（NAAT）、直接蛍光試験、マク...

注意欠陥多動性障害（ADHD）治療薬の世界市場：市場規模・現状・予測

Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size, Status and Forecast 2019-2025
QYR9ST04380 2019年9月2日 93Pages
※当調査レポートでは、注意欠陥多動性障害（ADHD）治療薬の世界市場について調査・分析し、注意欠陥多動性障害（ADHD）治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（覚せい剤、非興奮剤）、用...

急性リンパ性/リンパ芽球性白血病（ALL）治療薬の世界市場：市場規模・現状・予測

Global Acute Lymphocytic/Lymphoblastic Leukemia (ALL) Therapeutics Market Size, Status and Forecast 2019-2025
QYR9ST05752 2019年9月2日 96Pages
※当調査レポートでは、急性リンパ性/リンパ芽球性白血病（ALL）治療薬の世界市場について調査・分析し、急性リンパ性/リンパ芽球性白血病（ALL）治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（...

急性リンパ性/リンパ芽球性白血病（ALL）治療薬の世界市場：市場規模・現状・予測

全身性エリテマトーデスSLE治療薬の世界市場：インサイト・予測 Systemic Lupus Erythematous SLE Drug is an autoimmune disease involving multiple systems, multiple organs, and multiple autoantibodies.The global Systemic Lupus Erythematous SLE Drug market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx%…
ペットフードの世界市場：インサイト・予測 With changing lifestyle and growing concerns over animal health, consumers have been spending more on high-quality food. Pet owners are making sure that the products they buy are best suited for their requirements and contain all the necessary nutrition.The global Pet Foods market is valued at xx mi…
経口制御放出ドラッグデリバリーテクノロジーの世界市場：インサイト・予測 The combination of various technologies helps in rapidly overcoming problems associated with poorly soluble candidates. This is being aided through greater technology sharing through various conferences and symposiums where companies sharing similar thought processes meet and plan eventual outcomes.…
世界の経口抗糖尿病薬市場：専門的調査 Anti-diabetic drug refers to the medications consumed orally that are prescribed to treat diabetes mellitus (type 2). It treats diabetes (type 2) by lowering down the blood sugar level. These are also known as oral hypoglycemic agents or oral antihyperglycemic agents. Oral anti-diabetic drugs are of…
アフィニトール薬の世界市場：インサイト・予測 Everolimus is the 40-O-(2-hydroxyethyl) derivative of sirolimus and works similarly to sirolimus as an inhibitor of mammalian target of rapamycin (mTOR).The global Afinitor Drug market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% duri…